Researchers at Osaka University discovered that tricaprin, a natural supplement, significantly improves survival rates in ...

A new gene therapy reversed heart failure in pigs by repairing heart function through cBIN1, showing major promise for future ...

About 6.7 million adults in the U.S. are living with heart failure, and that number is expected to increase to more than 8 ...

As a pharmaceutical executive with a deep-rooted passion for expanding access to life-saving therapies, Seyi Alli has led the ...

A 2019 meta‐analysis estimates the following survival rates for all-type heart failure: 1 year: 87% 2 years: 73% 5 years: 57% 10 years: 35% However, life expectancy for a person with CHF has ...

Despite an increase in prescription rates of mineralocorticoid receptor antagonists (MRAs) for patients with heart failure with reduced ... their symptomatic relief, survival benefits, and cost ...

About 6.7 million adults in the U.S. are living with heart failure, and that number is expected to increase to more than 8 million by 2030.

A new analysis published in Circulation: Heart Failure shows ... year mortality rate. Although clinical trials have shown that quadruple therapy can significantly improve survival, use of this ...

Left untreated, RSOVA often leads to heart failure and death within a year. However, with early diagnosis and surgical repair, the long-term survival rate is typically strong. Doctors who ...

New findings from multiple studies demonstrate that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of ...

Use of routine thoracentesis in addition to medical therapy yielded no significant benefits for adults with heart failure and pleural ... (3% in each group), and survival probability (P ...

Launched in 2021, the American Heart Association’s three-year quality improvement initiative was designed to drive the uptake ...